Jazz Pharmaceuticals
JAZZ
#2037
Rank
NZ$13.39 B
Marketcap
$220.49
Share price
1.16%
Change (1 day)
11.97%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2024 (TTM): NZ$0.77 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are NZ$4.06 Billion. , an increase over its 2023 earnings that were of NZ$0.51 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 NZ$0.82 B57.87%
2023 NZ$0.51 B-179.92%
2022 -NZ$0.66 Billion230.37%
2021 -NZ$0.2 Billion-141.02%
2020 NZ$0.47 B-39.45%
2019 NZ$0.79 B-14.2%
2018 NZ$0.92 B20.03%
2017 NZ$0.76 B-17.15%
2016 NZ$0.92 B22.14%
2015 NZ$0.76 B187.64%
2014 NZ$0.26 B-50.79%
2013 NZ$0.53 B73.63%
2012 NZ$0.30 B41.69%
2011 NZ$0.21 B116.61%
2010 NZ$0.10 B262.77%
2009 NZ$27.77 M-111.33%
2008 -NZ$0.25 Billion1.31%
2007 -NZ$0.25 Billion77.8%
2006 -NZ$0.14 Billion36.59%
2005 -NZ$99.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$4.18 Billion-608.54%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$3.65 B 345.78%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$23.78 B 2,799.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-NZ$0.5 Billion-159.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel